U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by EULAV Asset Management

EULAV Asset Management lessened its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 41.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,700 shares of the company’s stock after selling 18,000 shares during the quarter. EULAV Asset Management owned about 0.17% of U.S. Physical Therapy worth $2,280,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Precision Wealth Strategies LLC boosted its holdings in U.S. Physical Therapy by 5.1% in the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock valued at $239,000 after acquiring an additional 137 shares during the last quarter. Albert D Mason Inc. raised its holdings in shares of U.S. Physical Therapy by 1.3% in the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock worth $940,000 after purchasing an additional 139 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of U.S. Physical Therapy by 1.0% in the 4th quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company’s stock valued at $1,450,000 after purchasing an additional 156 shares in the last quarter. Martin Capital Advisors LLP lifted its stake in shares of U.S. Physical Therapy by 1.6% in the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after purchasing an additional 201 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its holdings in shares of U.S. Physical Therapy by 25.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after purchasing an additional 298 shares during the period.

Analyst Ratings Changes

Several research firms recently commented on USPH. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the company from $100.00 to $115.00 in a report on Monday, December 16th. JMP Securities initiated coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target for the company. JPMorgan Chase & Co. boosted their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, U.S. Physical Therapy presently has a consensus rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Stock Down 0.9 %

Shares of NYSE USPH opened at $86.97 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The stock’s 50-day simple moving average is $91.29 and its 200-day simple moving average is $88.51. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 92.52, a PEG ratio of 3.61 and a beta of 1.48.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the transaction, the director now directly owns 16,726 shares in the company, valued at approximately $1,554,681.70. This represents a 10.68 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.